Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype

被引:33
作者
Bhattacharyya, D
Brooks, BR
Callahan, L
机构
[1] NIH, DIV COMP RES & TECHNOL, STRUCT BIOL LAB, BETHESDA, MD 20892 USA
[2] US PHARMACOPEIAL CONVENT INC, ROCKVILLE, MD 20852 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; PRINCIPAL NEUTRALIZING DETERMINANT; HEPARAN-SULFATE PROTEOGLYCANS; BIOLOGICAL PHENOTYPE; DEXTRAN SULFATE; INFECTION; DOMAIN; GP120; PROGRESSION; CAPACITY;
D O I
10.1089/aid.1996.12.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the V3 loop of the envelope glycoprotein (gp120) plays a role in determining the phenotype, pathogenesis, and tropism of human immunodeficiency virus-1 (HIV-1), there has not been any consistent correlation between structure and phenotype, Theoretically determined structures of the V3 loop of gp120, from 20 different viral strains, 10 syncytium-inducing (SI) and 10 non-syncytium-inducing (NSI) phenotype, revealed that all V3 loops from SI phenotypic strains had at least two positively charged residues in close proximity, on the same face of the loop, All of the SI phenotypic V3 loop structures were capable of forming strong divalent electrostatic interactions with disulfated sugars. The ability to form this interaction may be a determinant of the phenotype, tropism, and pathogenicity of HIV-1 viral strains, This structural motif was absent in all V3 loops from viral strains with the NSI phenotype.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 47 条
  • [1] ASJO B, 1986, LANCET, V2, P660
  • [2] BIOLOGY OF THE SYNDECANS - A FAMILY OF TRANSMEMBRANE HEPARAN-SULFATE PROTEOGLYCANS
    BERNFIELD, M
    KOKENYESI, R
    KATO, M
    HINKES, MT
    SPRING, J
    GALLO, RL
    LOSE, EJ
    [J]. ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 : 365 - 393
  • [3] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [4] HIV-1 VIRION-CELL INTERACTIONS - AN ELECTROSTATIC MODEL OF PATHOGENICITY AND SYNCYTIUM FORMATION
    CALLAHAN, L
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (03) : 231 - 233
  • [5] DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS
    CALLAHAN, LN
    PHELAN, M
    MALLINSON, M
    NORCROSS, MA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (03) : 1543 - 1550
  • [6] CARDIN AD, 1991, METHOD ENZYMOL, V203, P556
  • [7] SOLUTION CONFORMATIONAL PREFERENCES OF IMMUNOGENIC PEPTIDES DERIVED FROM THE PRINCIPAL NEUTRALIZING DETERMINANT OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
    CHANDRASEKHAR, K
    PROFY, AT
    DYSON, HJ
    [J]. BIOCHEMISTRY, 1991, 30 (38) : 9187 - 9194
  • [8] BIOLOGIC FEATURES OF HIV-1 THAT CORRELATE WITH VIRULENCE IN THE HOST
    CHENGMAYER, C
    SETO, D
    TATENO, M
    LEVY, JA
    [J]. SCIENCE, 1988, 240 (4848) : 80 - 82
  • [9] INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS
    CONNOR, RI
    MOHRI, H
    CAO, YZ
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (04) : 1772 - 1777
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES CHIMERIC FOR THE ENVELOPE V3 DOMAIN DIFFER IN SYNCYTIUM FORMATION AND REPLICATION CAPACITY
    DEJONG, JJ
    GOUDSMIT, J
    KEULEN, W
    KLAVER, B
    KRONE, W
    TERSMETTE, M
    DERONDE, A
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (02) : 757 - 765